Intraperitoneal Delivery of Adaptive Natural Killer (NK)

Project: Research project

Project Details

Description

Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) with Intraperitoneal Interleukin- 2 in Women with Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
StatusActive
Effective start/end date7/1/177/30/22

Funding

  • Fate Therapeutics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.